PDB Short entry for 1H15 HEADER IMMUNE SYSTEM/TRANSFERASE 02-JUL-02 1H15 TITLE X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A TITLE 2 PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE CAVEAT 1H15 NAG G 2 HAS WRONG CHIRALITY AT ATOM C1 NAG D 1184 HAS WRONG CAVEAT 2 1H15 CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: ALPHA CHAIN, RESIDUES 26-207; COMPND 5 SYNONYM: HLA-DRA, MAJOR HISTOCOMPATIBILITY COMPLEX A CHAIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR BETA 1 CHAIN; COMPND 9 CHAIN: B, E; COMPND 10 FRAGMENT: BETA CHAIN, RESIDUES 30-219; COMPND 11 SYNONYM: HLA-DRB1, MAJOR HISTOCOMPATIBILITY COMPLEX B CHAIN; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: DNA POLYMERASE; COMPND 15 CHAIN: C, F; COMPND 16 FRAGMENT: RESIDUES 628-641; COMPND 17 SYNONYM: EPSTEIN BARR VIUS (EBV) DNA POLYMERASE; COMPND 18 EC: 2.7.7.7; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: S2; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 14 EXPRESSION_SYSTEM_CELL_LINE: S2; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 4; SOURCE 18 ORGANISM_COMMON: EPSTEIN BARR VIRUS; SOURCE 19 ORGANISM_TAXID: 10376; SOURCE 20 OTHER_DETAILS: THE PROTEIN OCCURS NATURALLY IN EBV BUT THE PEPTIDE SOURCE 21 WAS SYNTHESISED CHEMICALLY KEYWDS IMMUNE SYSTEM/TRANSFERASE, COMPLEX (MHC-ANTIGEN), IMMUNE SYSTEM, MHC, KEYWDS 2 HLA, CLASS II, DR2, DRB5, EBV, DNA POLYMERASE, DNA-DIRECTED DNA KEYWDS 3 POLYMERASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LANG,H.JACOBSEN,S.IKEMIZU,C.ANDERSSON,K.HARLOS,L.MADSEN,P.HJORTH, AUTHOR 2 L.SONDERGAARD,A.SVEJGAARD,K.WUCHERPFENNIG,D.I.STUART,J.I.BELL, AUTHOR 3 E.Y.JONES,L.FUGGER REVDAT 6 13-DEC-23 1H15 1 HETSYN REVDAT 5 29-JUL-20 1H15 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 27-JUN-12 1H15 1 JRNL REVDAT 3 28-SEP-11 1H15 1 CAVEAT REMARK HET FORMUL REVDAT 3 2 1 HETNAM HETSYN LINK SITE REVDAT 3 3 1 HETATM CONECT VERSN REVDAT 2 24-FEB-09 1H15 1 VERSN REVDAT 1 03-OCT-02 1H15 0 JRNL AUTH H.LANG,H.JACOBSEN,S.IKEMIZU,C.ANDERSSON,K.HARLOS,L.MADSEN, JRNL AUTH 2 P.HJORTH,L.SONDERGAARD,A.SVEJGAARD,K.WUCHERPFENNIG, JRNL AUTH 3 D.I.STUART,J.I.BELL,E.Y.JONES,L.FUGGER JRNL TITL A FUNCTIONAL AND STRUCTURAL BASIS FOR TCR CROSS-REACTIVITY JRNL TITL 2 IN MULTIPLE SCLEROSIS JRNL REF NAT.IMMUNOL. V. 3 940 2002 JRNL REFN ISSN 1529-2908 JRNL PMID 12244309 JRNL DOI 10.1038/NI835 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 64350.380 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 28750 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.256 REMARK 3 FREE R VALUE : 0.310 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1415 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.29 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3455 REMARK 3 BIN R VALUE (WORKING SET) : 0.4560 REMARK 3 BIN FREE R VALUE : 0.4790 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 197 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6320 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 30 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.37000 REMARK 3 B22 (A**2) : 2.37000 REMARK 3 B33 (A**2) : -4.74000 REMARK 3 B12 (A**2) : 12.75000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.49 REMARK 3 ESD FROM SIGMAA (A) : 0.87 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.62 REMARK 3 ESD FROM C-V SIGMAA (A) : 1.07 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.520 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.350 ; 3.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.540 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.900 ; 4.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 80.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1H15 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-JUL-02. REMARK 100 THE DEPOSITION ID IS D_1290009971. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 3.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : SI111 / SI311 CRYSTALS, LN2 REMARK 200 COOLED REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28750 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.41400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.77400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: SINGLE COPY OF 1FV1 (A AND B CHAINS) MINUS PEPTIDE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 3550, 100MM GLYCINE AND 10MM REMARK 280 TRIS AT PH 3.5-4.0., PH 3.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.92267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.96133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.44200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 15.48067 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 77.40333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 1 REMARK 465 LYS A 2 REMARK 465 GLY B 1 REMARK 465 ILE D 1 REMARK 465 LYS D 2 REMARK 465 GLY E 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 88 N - CA - C ANGL. DEV. = -16.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 37 -71.60 -49.88 REMARK 500 ARG A 50 -9.64 -57.28 REMARK 500 ARG A 76 -15.12 -46.95 REMARK 500 TYR A 79 58.00 31.91 REMARK 500 PRO A 87 -161.65 -58.72 REMARK 500 GLU A 88 102.73 -168.09 REMARK 500 LEU A 99 140.86 -37.89 REMARK 500 ARG A 100 23.86 47.12 REMARK 500 PRO A 102 145.75 -34.45 REMARK 500 THR A 113 147.24 165.92 REMARK 500 PRO A 115 67.96 -66.21 REMARK 500 ASN A 124 74.53 59.83 REMARK 500 LEU A 144 -161.44 -104.73 REMARK 500 PRO A 155 104.54 -44.23 REMARK 500 ASP A 181 71.87 83.18 REMARK 500 ASN B 33 -81.08 52.64 REMARK 500 GLN B 34 13.22 -145.88 REMARK 500 GLU B 52 -16.51 -49.87 REMARK 500 ARG B 55 -64.26 -26.07 REMARK 500 VAL B 75 -14.19 -46.64 REMARK 500 ASP B 76 -57.89 -122.17 REMARK 500 TYR B 78 -60.94 -107.05 REMARK 500 CYS B 79 -81.49 -60.54 REMARK 500 THR B 90 -69.81 -146.33 REMARK 500 ARG B 105 109.63 47.88 REMARK 500 GLN B 107 -36.63 -36.79 REMARK 500 TYR B 123 -86.36 -92.88 REMARK 500 PRO B 124 114.99 -32.17 REMARK 500 SER B 135 70.83 35.03 REMARK 500 GLN B 136 111.16 -170.62 REMARK 500 GLU B 138 50.43 -93.83 REMARK 500 LYS B 139 -15.32 -29.79 REMARK 500 PRO B 178 46.78 -55.37 REMARK 500 GLU D 4 -36.21 -131.36 REMARK 500 ALA D 37 -75.65 -47.85 REMARK 500 ARG D 76 9.73 -58.19 REMARK 500 ASN D 84 109.63 -58.73 REMARK 500 PRO D 96 168.49 -45.78 REMARK 500 LEU D 99 132.12 -33.35 REMARK 500 ARG D 100 -7.16 73.13 REMARK 500 PRO D 102 109.10 -49.10 REMARK 500 ASN D 103 -167.17 -116.25 REMARK 500 THR D 113 152.28 175.80 REMARK 500 PRO D 115 70.46 -66.05 REMARK 500 ASN D 124 -20.56 64.05 REMARK 500 THR D 130 95.99 -65.77 REMARK 500 VAL D 136 -125.47 -85.88 REMARK 500 HIS D 143 33.49 80.52 REMARK 500 LEU D 144 -164.48 -105.27 REMARK 500 PRO D 155 98.92 -32.85 REMARK 500 REMARK 500 THIS ENTRY HAS 82 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A6A RELATED DB: PDB REMARK 900 THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP REMARK 900 BOUND TO HLA-DR3 REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1D5M RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE REMARK 900 RELATED ID: 1D5X RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC REMARK 900 RELATED ID: 1D5Z RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC REMARK 900 RELATED ID: 1D6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB REMARK 900 RELATED ID: 1DLH RELATED DB: PDB REMARK 900 RELATED ID: 1FV1 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANTPEPTIDE FROM REMARK 900 MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES REMARK 900 RELATED ID: 1HQR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH-AFFINITY, REMARK 900 ZINC-DEPENDENT SITE ON MHC CLASS II REMARK 900 RELATED ID: 1HXY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H INCOMPLEX WITH REMARK 900 HUMAN MHC CLASS II REMARK 900 RELATED ID: 1J8H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELLRECEPTOR, REMARK 900 INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS IIMOLECULE, HLA-DR4 REMARK 900 RELATED ID: 1KG0 RELATED DB: PDB REMARK 900 STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TOTHE MHC REMARK 900 CLASS II RECEPTOR HLA-DR1 REMARK 900 RELATED ID: 1SEB RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 ANDTHE REMARK 900 BACTERIAL SUPERANTIGEN SEB REMARK 900 RELATED ID: 2SEB RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM REMARK 900 HUMAN COLLAGEN II REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 26-207 OF DATABASE SEQUENCE REMARK 999 RESIDUES 30-219 OF DATABASE SEQUENCE DBREF 1H15 A 1 182 UNP P01903 HA2R_HUMAN 26 207 DBREF 1H15 B 1 190 UNP Q30126 Q30126 30 219 DBREF 1H15 C 628 641 UNP P03198 DPOL_EBV 628 641 DBREF 1H15 D 1 182 UNP P01903 HA2R_HUMAN 26 207 DBREF 1H15 E 1 190 UNP Q30126 Q30126 30 219 DBREF 1H15 F 628 641 UNP P03198 DPOL_EBV 628 641 SEQRES 1 A 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 A 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 A 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 A 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 A 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 A 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 A 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 A 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 A 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 A 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 A 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 A 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 A 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 A 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP ALA SEQRES 1 B 190 GLY ASP THR ARG PRO ARG PHE LEU GLN GLN ASP LYS TYR SEQRES 2 B 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 B 190 LEU HIS ARG ASP ILE TYR ASN GLN GLU GLU ASP LEU ARG SEQRES 4 B 190 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 5 B 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 B 190 ASP PHE LEU GLU ASP ARG ARG ALA ALA VAL ASP THR TYR SEQRES 7 B 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 B 190 GLN ARG ARG VAL GLU PRO LYS VAL THR VAL TYR PRO ALA SEQRES 9 B 190 ARG THR GLN THR LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 B 190 SER VAL ASN GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 B 190 TRP PHE ARG ASN SER GLN GLU GLU LYS ALA GLY VAL VAL SEQRES 12 B 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 B 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 B 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 B 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 C 14 GLY GLY VAL TYR HIS PHE VAL LYS LYS HIS VAL HIS GLU SEQRES 2 C 14 SER SEQRES 1 D 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 D 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 D 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 D 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 D 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 D 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 D 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 D 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 D 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 D 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 D 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 D 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 D 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 D 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP ALA SEQRES 1 E 190 GLY ASP THR ARG PRO ARG PHE LEU GLN GLN ASP LYS TYR SEQRES 2 E 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 E 190 LEU HIS ARG ASP ILE TYR ASN GLN GLU GLU ASP LEU ARG SEQRES 4 E 190 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 5 E 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 E 190 ASP PHE LEU GLU ASP ARG ARG ALA ALA VAL ASP THR TYR SEQRES 7 E 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 E 190 GLN ARG ARG VAL GLU PRO LYS VAL THR VAL TYR PRO ALA SEQRES 9 E 190 ARG THR GLN THR LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 E 190 SER VAL ASN GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 E 190 TRP PHE ARG ASN SER GLN GLU GLU LYS ALA GLY VAL VAL SEQRES 12 E 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 E 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 E 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 E 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 F 14 GLY GLY VAL TYR HIS PHE VAL LYS LYS HIS VAL HIS GLU SEQRES 2 F 14 SER MODRES 1H15 ASN A 78 ASN GLYCOSYLATION SITE MODRES 1H15 ASN A 118 ASN GLYCOSYLATION SITE MODRES 1H15 ASN D 78 ASN GLYCOSYLATION SITE MODRES 1H15 ASN D 118 ASN GLYCOSYLATION SITE HET NAG G 1 14 HET NAG G 2 14 HET NAG A1185 14 HET NAG D1183 14 HET NAG D1184 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 NAG 5(C8 H15 N O6) FORMUL 11 HOH *30(H2 O) HELIX 1 1 LEU A 45 PHE A 51 1 7 HELIX 2 2 GLU A 55 ARG A 76 1 22 HELIX 3 3 GLN B 64 ALA B 73 1 10 HELIX 4 4 ALA B 73 TYR B 78 1 6 HELIX 5 5 TYR B 78 VAL B 85 5 8 HELIX 6 6 LEU D 45 PHE D 51 1 7 HELIX 7 7 GLU D 55 ARG D 76 1 22 HELIX 8 8 GLN E 64 ALA E 73 1 10 HELIX 9 9 ALA E 73 TYR E 78 1 6 HELIX 10 10 TYR E 78 VAL E 85 5 8 SHEET 1 AA 8 GLU A 40 TRP A 43 0 SHEET 2 AA 8 ASP A 29 ASP A 35 -1 O HIS A 33 N VAL A 42 SHEET 3 AA 8 SER A 19 PHE A 26 -1 O PHE A 22 N VAL A 34 SHEET 4 AA 8 HIS A 5 ASN A 15 -1 O ILE A 8 N ASP A 25 SHEET 5 AA 8 PHE B 7 PHE B 18 -1 O PHE B 7 N ASN A 15 SHEET 6 AA 8 ARG B 23 TYR B 32 -1 O ARG B 23 N PHE B 18 SHEET 7 AA 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AB 2 ALA A 52 SER A 53 0 SHEET 2 AB 2 GLY C 629 VAL C 630 1 O GLY C 629 N SER A 53 SHEET 1 AC 4 VAL A 89 THR A 93 0 SHEET 2 AC 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AC 4 PHE A 145 PHE A 153 -1 O PHE A 145 N PHE A 112 SHEET 4 AC 4 SER A 133 GLU A 134 -1 O SER A 133 N TYR A 150 SHEET 1 AD 4 VAL A 89 THR A 93 0 SHEET 2 AD 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AD 4 PHE A 145 PHE A 153 -1 O PHE A 145 N PHE A 112 SHEET 4 AD 4 LEU A 138 PRO A 139 -1 O LEU A 138 N ARG A 146 SHEET 1 AE 4 LYS A 126 VAL A 128 0 SHEET 2 AE 4 VAL A 117 ARG A 123 -1 O TRP A 121 N VAL A 128 SHEET 3 AE 4 VAL A 160 HIS A 167 -1 O ASP A 162 N LEU A 122 SHEET 4 AE 4 LEU A 174 GLU A 179 -1 O LEU A 174 N VAL A 165 SHEET 1 BA 4 VAL B 101 ALA B 104 0 SHEET 2 BA 4 ASN B 113 PHE B 122 -1 O LEU B 114 N ALA B 104 SHEET 3 BA 4 PHE B 155 THR B 163 -1 O PHE B 155 N GLY B 121 SHEET 4 BA 4 VAL B 142 SER B 144 -1 O VAL B 143 N MET B 160 SHEET 1 BB 4 VAL B 101 ALA B 104 0 SHEET 2 BB 4 ASN B 113 PHE B 122 -1 O LEU B 114 N ALA B 104 SHEET 3 BB 4 PHE B 155 THR B 163 -1 O PHE B 155 N GLY B 121 SHEET 4 BB 4 ILE B 148 GLN B 149 -1 O ILE B 148 N GLN B 156 SHEET 1 BC 3 GLU B 128 ARG B 133 0 SHEET 2 BC 3 VAL B 170 GLU B 176 -1 O THR B 172 N PHE B 132 SHEET 3 BC 3 LEU B 184 ARG B 189 -1 O LEU B 184 N VAL B 175 SHEET 1 DA 8 GLU D 40 TRP D 43 0 SHEET 2 DA 8 ASP D 29 ASP D 35 -1 O HIS D 33 N VAL D 42 SHEET 3 DA 8 SER D 19 PHE D 26 -1 O PHE D 22 N VAL D 34 SHEET 4 DA 8 HIS D 5 LEU D 14 -1 O ILE D 8 N ASP D 25 SHEET 5 DA 8 LEU E 8 PHE E 18 -1 O GLN E 9 N TYR D 13 SHEET 6 DA 8 ARG E 23 TYR E 32 -1 O ARG E 23 N PHE E 18 SHEET 7 DA 8 GLU E 35 ASP E 41 -1 O GLU E 35 N TYR E 32 SHEET 8 DA 8 TYR E 47 ALA E 49 -1 O ARG E 48 N ARG E 39 SHEET 1 DB 2 ALA D 52 SER D 53 0 SHEET 2 DB 2 GLY F 629 VAL F 630 1 O GLY F 629 N SER D 53 SHEET 1 DC 4 GLU D 88 THR D 93 0 SHEET 2 DC 4 ASN D 103 PHE D 112 -1 O ILE D 106 N LEU D 92 SHEET 3 DC 4 PHE D 145 PHE D 153 -1 O PHE D 145 N PHE D 112 SHEET 4 DC 4 LEU D 138 PRO D 139 -1 O LEU D 138 N ARG D 146 SHEET 1 DD 4 LYS D 126 PRO D 127 0 SHEET 2 DD 4 THR D 120 ARG D 123 -1 O ARG D 123 N LYS D 126 SHEET 3 DD 4 TYR D 161 VAL D 165 -1 O ASP D 162 N LEU D 122 SHEET 4 DD 4 LEU D 174 TRP D 178 -1 O LEU D 174 N VAL D 165 SHEET 1 EA 4 LYS E 98 PRO E 103 0 SHEET 2 EA 4 LEU E 115 ASN E 120 -1 O VAL E 116 N TYR E 102 SHEET 3 EA 4 GLN E 156 LEU E 161 -1 O THR E 157 N VAL E 119 SHEET 4 EA 4 VAL E 142 SER E 144 -1 O VAL E 143 N MET E 160 SHEET 1 EB 4 GLN E 136 GLU E 138 0 SHEET 2 EB 4 GLU E 128 ARG E 133 -1 O TRP E 131 N GLU E 138 SHEET 3 EB 4 VAL E 170 GLU E 176 -1 O THR E 172 N PHE E 132 SHEET 4 EB 4 LEU E 184 ARG E 189 -1 O LEU E 184 N VAL E 175 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.02 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.03 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.02 SSBOND 4 CYS D 107 CYS D 163 1555 1555 2.03 SSBOND 5 CYS E 15 CYS E 79 1555 1555 2.04 SSBOND 6 CYS E 117 CYS E 173 1555 1555 2.03 LINK ND2 ASN A 78 C1 NAG A1185 1555 1555 1.46 LINK ND2 ASN A 118 C1 NAG G 1 1555 1555 1.45 LINK ND2 ASN D 78 C1 NAG D1184 1555 1555 1.46 LINK ND2 ASN D 118 C1 NAG D1183 1555 1555 1.45 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.39 CISPEP 1 ASN A 15 PRO A 16 0 0.42 CISPEP 2 THR A 113 PRO A 114 0 0.33 CISPEP 3 THR D 113 PRO D 114 0 -0.21 CRYST1 179.244 179.244 92.884 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005579 0.003221 0.000000 0.00000 SCALE2 0.000000 0.006442 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010766 0.00000